Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 62 diseases |
IL1B 1件: IL1B 💬African trypanosomiasis
|
Canakinumab Canakinumab 💬African trypanosomiasis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬1. African trypanosomiasis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 62 diseases |
IL1B 1件: IL1B 💬African trypanosomiasis
|
Rilonacept Rilonacept 💬African trypanosomiasis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬AGE-RAGE signaling pathway in diabetic complications
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬3. AGE-RAGE signaling pathway in diabetic complications |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
IL1B 1件: IL1B 💬AGE-RAGE signaling pathway in diabetic complications
|
Canakinumab Canakinumab 💬AGE-RAGE signaling pathway in diabetic complications
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬4. AGE-RAGE signaling pathway in diabetic complications
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
IL1B 1件: IL1B 💬Alcoholic liver disease
|
Canakinumab Canakinumab 💬Alcoholic liver disease
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬5. Alcoholic liver disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Alcoholic liver disease 💬 42 genes, 54 drugs (DrugBank) and 91 diseases |
IL1B 1件: IL1B 💬Alcoholic liver disease
|
Rilonacept Rilonacept 💬Alcoholic liver disease
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Alzheimer disease
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
IL1B 1件: IL1B 💬Alzheimer disease
|
Canakinumab Canakinumab 💬Alzheimer disease
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬8. Alzheimer disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Alzheimer disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬9. Alzheimer disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
IL1B 1件: IL1B 💬Amoebiasis
|
Canakinumab Canakinumab 💬Amoebiasis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬10. Amoebiasis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
IL1B 1件: IL1B 💬Amoebiasis
|
Rilonacept Rilonacept 💬Amoebiasis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
IL1R1 2件: IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Amoebiasis
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬12. Amoebiasis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Amyotrophic lateral sclerosis 💬 38 genes, 55 drugs (DrugBank) and 109 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Amyotrophic lateral sclerosis
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬13. Amyotrophic lateral sclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
IL1B 1件: IL1B 💬C-type lectin receptor signaling pathway
|
Canakinumab Canakinumab 💬C-type lectin receptor signaling pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬14. C-type lectin receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
IL1B 1件: IL1B 💬C-type lectin receptor signaling pathway
|
Rilonacept Rilonacept 💬C-type lectin receptor signaling pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬15. C-type lectin receptor signaling pathway |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
IL1A 1件: IL1A 💬Cellular senescence
|
Rilonacept Rilonacept 💬Cellular senescence
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
IL1B 1件: IL1B 💬Chagas disease
|
Canakinumab Canakinumab 💬Chagas disease
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬17. Chagas disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
IL1B 1件: IL1B 💬Chagas disease
|
Rilonacept Rilonacept 💬Chagas disease
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
IL1B 1件: IL1B 💬Coronavirus disease - COVID-19
|
Canakinumab Canakinumab 💬Coronavirus disease - COVID-19
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬19. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
IL1B 1件: IL1B 💬Coronavirus disease - COVID-19
|
Rilonacept Rilonacept 💬Coronavirus disease - COVID-19
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬20. Coronavirus disease - COVID-19 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
IL6R 1件: IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Coronavirus disease - COVID-19
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬21. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Cytokine-cytokine receptor interaction
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬22. Cytokine-cytokine receptor interaction |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL1B 1件: IL1B 💬Cytokine-cytokine receptor interaction
|
Canakinumab Canakinumab 💬Cytokine-cytokine receptor interaction
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬23. Cytokine-cytokine receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL1R1 2件: IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Cytokine-cytokine receptor interaction
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬24. Cytokine-cytokine receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL6R 1件: IL6R 💬Cytokine-cytokine receptor interaction
|
Tocilizumab Tocilizumab 💬Cytokine-cytokine receptor interaction
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬25. Cytokine-cytokine receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | Cytosolic DNA-sensing pathway 💬 20 genes, 16 drugs (DrugBank) and 31 diseases |
IL1B 1件: IL1B 💬Cytosolic DNA-sensing pathway
|
Canakinumab Canakinumab 💬Cytosolic DNA-sensing pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬26. Cytosolic DNA-sensing pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | Cytosolic DNA-sensing pathway 💬 20 genes, 16 drugs (DrugBank) and 31 diseases |
IL1B 1件: IL1B 💬Cytosolic DNA-sensing pathway
|
Rilonacept Rilonacept 💬Cytosolic DNA-sensing pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬27. Cytosolic DNA-sensing pathway |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Fluid shear stress and atherosclerosis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬28. Fluid shear stress and atherosclerosis |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
IL1B 1件: IL1B 💬Fluid shear stress and atherosclerosis
|
Canakinumab Canakinumab 💬Fluid shear stress and atherosclerosis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬29. Fluid shear stress and atherosclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
IL1R1 2件: IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Fluid shear stress and atherosclerosis
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬30. Fluid shear stress and atherosclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Gap junction
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬31. Gap junction
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Graft-versus-host disease 💬 28 genes, 25 drugs (DrugBank) and 64 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Graft-versus-host disease
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Graft-versus-host disease 💬 28 genes, 25 drugs (DrugBank) and 64 diseases |
IL1B 1件: IL1B 💬Graft-versus-host disease
|
Canakinumab Canakinumab 💬Graft-versus-host disease
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬33. Graft-versus-host disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Hematopoietic cell lineage
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
IL1B 1件: IL1B 💬Hematopoietic cell lineage
|
Canakinumab Canakinumab 💬Hematopoietic cell lineage
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬35. Hematopoietic cell lineage
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
IL1R1 2件: IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Hematopoietic cell lineage
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬36. Hematopoietic cell lineage
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
IL6R 1件: IL6R 💬Hematopoietic cell lineage
|
Tocilizumab Tocilizumab 💬Hematopoietic cell lineage
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬37. Hematopoietic cell lineage
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
IL1B 1件: IL1B 💬Herpes simplex virus 1 infection
|
Canakinumab Canakinumab 💬Herpes simplex virus 1 infection
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬38. Herpes simplex virus 1 infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
IL1B 1件: IL1B 💬Herpes simplex virus 1 infection
|
Rilonacept Rilonacept 💬Herpes simplex virus 1 infection
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬39. Herpes simplex virus 1 infection |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
IL6R 1件: IL6R 💬HIF-1 signaling pathway
|
Tocilizumab Tocilizumab 💬HIF-1 signaling pathway
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬40. HIF-1 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
IL1B 1件: IL1B 💬Human cytomegalovirus infection
|
Canakinumab Canakinumab 💬Human cytomegalovirus infection
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬41. Human cytomegalovirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
IL1B 1件: IL1B 💬Human cytomegalovirus infection
|
Rilonacept Rilonacept 💬Human cytomegalovirus infection
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬42. Human cytomegalovirus infection |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
IL1R1 1件: IL1R1 💬Human cytomegalovirus infection
|
Anakinra Anakinra 💬Human cytomegalovirus infection
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬43. Human cytomegalovirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
IL6R 1件: IL6R 💬Human cytomegalovirus infection
|
Tocilizumab Tocilizumab 💬Human cytomegalovirus infection
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬44. Human cytomegalovirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
IL1R1 2件: IL1R1, IL1R2 💬
|
Anakinra Anakinra 💬Human T-cell leukemia virus 1 infection
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬45. Human T-cell leukemia virus 1 infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Huntington disease 💬 26 genes, 39 drugs (DrugBank) and 87 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Huntington disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬46. Huntington disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
IL1B 1件: IL1B 💬IL-17 signaling pathway
|
Canakinumab Canakinumab 💬IL-17 signaling pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬47. IL-17 signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | IL-17 signaling pathway 💬 20 genes, 61 drugs (DrugBank) and 86 diseases |
IL1B 1件: IL1B 💬IL-17 signaling pathway
|
Rilonacept Rilonacept 💬IL-17 signaling pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Inflammatory bowel disease
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Inflammatory bowel disease 💬 37 genes, 46 drugs (DrugBank) and 70 diseases |
IL1B 1件: IL1B 💬Inflammatory bowel disease
|
Canakinumab Canakinumab 💬Inflammatory bowel disease
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬50. Inflammatory bowel disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
IL1B 1件: IL1B 💬Inflammatory mediator regulation of TRP channels
|
Canakinumab Canakinumab 💬Inflammatory mediator regulation of TRP channels
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬51. Inflammatory mediator regulation of TRP channels
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
IL1B 1件: IL1B 💬Inflammatory mediator regulation of TRP channels
|
Rilonacept Rilonacept 💬Inflammatory mediator regulation of TRP channels
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬52. Inflammatory mediator regulation of TRP channels |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
IL1R1 1件: IL1R1 💬Inflammatory mediator regulation of TRP channels
|
Anakinra Anakinra 💬Inflammatory mediator regulation of TRP channels
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬53. Inflammatory mediator regulation of TRP channels
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Influenza A
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
IL1B 1件: IL1B 💬Influenza A
|
Canakinumab Canakinumab 💬Influenza A
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬55. Influenza A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
IL6R 1件: IL6R 💬JAK-STAT signaling pathway
|
Tocilizumab Tocilizumab 💬JAK-STAT signaling pathway
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬56. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Legionellosis 💬 9 genes, 23 drugs (DrugBank) and 64 diseases |
IL1B 1件: IL1B 💬Legionellosis
|
Canakinumab Canakinumab 💬Legionellosis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬57. Legionellosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Legionellosis 💬 9 genes, 23 drugs (DrugBank) and 64 diseases |
IL1B 1件: IL1B 💬Legionellosis
|
Rilonacept Rilonacept 💬Legionellosis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Leishmaniasis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | Leishmaniasis 💬 40 genes, 68 drugs (DrugBank) and 102 diseases |
IL1B 1件: IL1B 💬Leishmaniasis
|
Canakinumab Canakinumab 💬Leishmaniasis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬60. Leishmaniasis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
IL1B 1件: IL1B 💬Lipid and atherosclerosis
|
Canakinumab Canakinumab 💬Lipid and atherosclerosis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬61. Lipid and atherosclerosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
IL1B 1件: IL1B 💬Lipid and atherosclerosis
|
Rilonacept Rilonacept 💬Lipid and atherosclerosis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | Malaria 💬 16 genes, 32 drugs (DrugBank) and 71 diseases |
IL1B 1件: IL1B 💬Malaria
|
Canakinumab Canakinumab 💬Malaria
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬63. Malaria
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Malaria 💬 16 genes, 32 drugs (DrugBank) and 71 diseases |
IL1B 1件: IL1B 💬Malaria
|
Rilonacept Rilonacept 💬Malaria
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬MAPK signaling pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
IL1B 1件: IL1B 💬MAPK signaling pathway
|
Canakinumab Canakinumab 💬MAPK signaling pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬66. MAPK signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
IL1R1 1件: IL1R1 💬MAPK signaling pathway
|
Anakinra Anakinra 💬MAPK signaling pathway
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬67. MAPK signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | Measles 💬 42 genes, 63 drugs (DrugBank) and 68 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Measles
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | Measles 💬 42 genes, 63 drugs (DrugBank) and 68 diseases |
IL1B 1件: IL1B 💬Measles
|
Canakinumab Canakinumab 💬Measles
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬69. Measles
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | Motor proteins 💬 25 genes, 10 drugs (DrugBank) and 21 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Motor proteins
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬70. Motor proteins
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | Necroptosis 💬 32 genes, 52 drugs (DrugBank) and 77 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Necroptosis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Necroptosis 💬 32 genes, 52 drugs (DrugBank) and 77 diseases |
IL1B 1件: IL1B 💬Necroptosis
|
Canakinumab Canakinumab 💬Necroptosis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬72. Necroptosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | NF-kappa B signaling pathway 💬 22 genes, 77 drugs (DrugBank) and 91 diseases |
IL1B 1件: IL1B 💬NF-kappa B signaling pathway
|
Canakinumab Canakinumab 💬NF-kappa B signaling pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬73. NF-kappa B signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | NF-kappa B signaling pathway 💬 22 genes, 77 drugs (DrugBank) and 91 diseases |
IL1B 1件: IL1B 💬NF-kappa B signaling pathway
|
Rilonacept Rilonacept 💬NF-kappa B signaling pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬74. NF-kappa B signaling pathway |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | NF-kappa B signaling pathway 💬 22 genes, 77 drugs (DrugBank) and 91 diseases |
IL1R1 1件: IL1R1 💬NF-kappa B signaling pathway
|
Anakinra Anakinra 💬NF-kappa B signaling pathway
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬75. NF-kappa B signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | NOD-like receptor signaling pathway 💬 32 genes, 51 drugs (DrugBank) and 74 diseases |
IL1B 1件: IL1B 💬NOD-like receptor signaling pathway
|
Canakinumab Canakinumab 💬NOD-like receptor signaling pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬76. NOD-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | NOD-like receptor signaling pathway 💬 32 genes, 51 drugs (DrugBank) and 74 diseases |
IL1B 1件: IL1B 💬NOD-like receptor signaling pathway
|
Rilonacept Rilonacept 💬NOD-like receptor signaling pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬77. NOD-like receptor signaling pathway |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Non-alcoholic fatty liver disease
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬78. Non-alcoholic fatty liver disease |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
IL1B 1件: IL1B 💬Non-alcoholic fatty liver disease
|
Canakinumab Canakinumab 💬Non-alcoholic fatty liver disease
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬79. Non-alcoholic fatty liver disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
IL6R 1件: IL6R 💬Non-alcoholic fatty liver disease
|
Tocilizumab Tocilizumab 💬Non-alcoholic fatty liver disease
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬80. Non-alcoholic fatty liver disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Osteoclast differentiation
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
IL1B 1件: IL1B 💬Osteoclast differentiation
|
Canakinumab Canakinumab 💬Osteoclast differentiation
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬82. Osteoclast differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
IL1R1 1件: IL1R1 💬Osteoclast differentiation
|
Anakinra Anakinra 💬Osteoclast differentiation
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬83. Osteoclast differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Parkinson disease 💬 24 genes, 76 drugs (DrugBank) and 68 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Parkinson disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬84. Parkinson disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
IL1B 1件: IL1B 💬Pathogenic Escherichia coli infection
|
Canakinumab Canakinumab 💬Pathogenic Escherichia coli infection
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬85. Pathogenic Escherichia coli infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
IL1B 1件: IL1B 💬Pathogenic Escherichia coli infection
|
Rilonacept Rilonacept 💬Pathogenic Escherichia coli infection
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬86. Pathogenic Escherichia coli infection |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
IL1R1 1件: IL1R1 💬Pathogenic Escherichia coli infection
|
Anakinra Anakinra 💬Pathogenic Escherichia coli infection
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬87. Pathogenic Escherichia coli infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Pathogenic Escherichia coli infection
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬88. Pathogenic Escherichia coli infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
IL6R 1件: IL6R 💬Pathways in cancer
|
Tocilizumab Tocilizumab 💬Pathways in cancer
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬89. Pathways in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Pathways of neurodegeneration - multiple diseases
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬90. Pathways of neurodegeneration - multiple diseases |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
IL1B 1件: IL1B 💬Pathways of neurodegeneration - multiple diseases
|
Canakinumab Canakinumab 💬Pathways of neurodegeneration - multiple diseases
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬91. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Pathways of neurodegeneration - multiple diseases
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬92. Pathways of neurodegeneration - multiple diseases
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | Pertussis 💬 22 genes, 46 drugs (DrugBank) and 73 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Pertussis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | Pertussis 💬 22 genes, 46 drugs (DrugBank) and 73 diseases |
IL1B 1件: IL1B 💬Pertussis
|
Canakinumab Canakinumab 💬Pertussis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬94. Pertussis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | Phagosome 💬 37 genes, 16 drugs (DrugBank) and 30 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Phagosome
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬95. Phagosome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6R 1件: IL6R 💬PI3K-Akt signaling pathway
|
Tocilizumab Tocilizumab 💬PI3K-Akt signaling pathway
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬96. PI3K-Akt signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Prion disease
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
IL1B 1件: IL1B 💬Prion disease
|
Canakinumab Canakinumab 💬Prion disease
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬98. Prion disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Prion disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬99. Prion disease
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
IL1R2 1件: IL1R2 💬Prostate cancer
|
Anakinra Anakinra 💬Prostate cancer
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬100. Prostate cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
101 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Rheumatoid arthritis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
102 | Rheumatoid arthritis 💬 38 genes, 59 drugs (DrugBank) and 87 diseases |
IL1B 1件: IL1B 💬Rheumatoid arthritis
|
Canakinumab Canakinumab 💬Rheumatoid arthritis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬102. Rheumatoid arthritis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
103 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
IL1B 1件: IL1B 💬Salmonella infection
|
Canakinumab Canakinumab 💬Salmonella infection
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬103. Salmonella infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
104 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
IL1B 1件: IL1B 💬Salmonella infection
|
Rilonacept Rilonacept 💬Salmonella infection
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
105 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
TUBB 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
|
Colchicine Colchicine 💬Salmonella infection
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬105. Salmonella infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
106 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
IL1B 1件: IL1B 💬Shigellosis
|
Canakinumab Canakinumab 💬Shigellosis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬106. Shigellosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
107 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
IL1B 1件: IL1B 💬Shigellosis
|
Rilonacept Rilonacept 💬Shigellosis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
108 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
IL1R1 1件: IL1R1 💬Shigellosis
|
Anakinra Anakinra 💬Shigellosis
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬108. Shigellosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
109 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL1B 1件: IL1B 💬Th17 cell differentiation
|
Canakinumab Canakinumab 💬Th17 cell differentiation
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬109. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
110 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL1B 1件: IL1B 💬Th17 cell differentiation
|
Rilonacept Rilonacept 💬Th17 cell differentiation
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
111 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL1R1 1件: IL1R1 💬Th17 cell differentiation
|
Anakinra Anakinra 💬Th17 cell differentiation
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬111. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
112 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL6R 1件: IL6R 💬Th17 cell differentiation
|
Tocilizumab Tocilizumab 💬Th17 cell differentiation
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬112. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
113 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
IL1B 1件: IL1B 💬TNF signaling pathway
|
Canakinumab Canakinumab 💬TNF signaling pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬113. TNF signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
114 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
IL1B 1件: IL1B 💬TNF signaling pathway
|
Rilonacept Rilonacept 💬TNF signaling pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
115 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
IL1B 1件: IL1B 💬Toll-like receptor signaling pathway
|
Canakinumab Canakinumab 💬Toll-like receptor signaling pathway
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬115. Toll-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
116 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
IL1B 1件: IL1B 💬Toll-like receptor signaling pathway
|
Rilonacept Rilonacept 💬Toll-like receptor signaling pathway
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬116. Toll-like receptor signaling pathway |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
117 | Transcriptional misregulation in cancer 💬 28 genes, 60 drugs (DrugBank) and 79 diseases |
IL1R2 1件: IL1R2 💬Transcriptional misregulation in cancer
|
Anakinra Anakinra 💬Transcriptional misregulation in cancer
| Anakinra | 002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬117. Transcriptional misregulation in cancer
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
118 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Tuberculosis
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
119 | Tuberculosis 💬 66 genes, 73 drugs (DrugBank) and 98 diseases |
IL1B 1件: IL1B 💬Tuberculosis
|
Canakinumab Canakinumab 💬Tuberculosis
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬119. Tuberculosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
120 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 70 diseases |
IL1A 2件: IL1A, IL1B 💬
|
Rilonacept Rilonacept 💬Type I diabetes mellitus
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
121 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 70 diseases |
IL1B 1件: IL1B 💬Type I diabetes mellitus
|
Canakinumab Canakinumab 💬Type I diabetes mellitus
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬121. Type I diabetes mellitus
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
122 | Viral protein interaction with cytokine and cytokine receptor 💬 17 genes, 32 drugs (DrugBank) and 68 diseases |
IL6R 1件: IL6R 💬Viral protein interaction with cytokine and cytokine receptor
|
Tocilizumab Tocilizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Tocilizumab | 002 24件: 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬122. Viral protein interaction with cytokine and cytokine receptor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
123 | Yersinia infection 💬 27 genes, 45 drugs (DrugBank) and 79 diseases |
IL1B 1件: IL1B 💬Yersinia infection
|
Canakinumab Canakinumab 💬Yersinia infection
| Canakinumab | 046 11件: 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬123. Yersinia infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
124 | Yersinia infection 💬 27 genes, 45 drugs (DrugBank) and 79 diseases |
IL1B 1件: IL1B 💬Yersinia infection
|
Rilonacept Rilonacept 💬Yersinia infection
| Rilonacept | 051 5件: 51, 84, 106, 107, 266 💬
|
African trypanosomiasis
10 genes, 24 drugs (DrugBank) and 62 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Alcoholic liver disease
42 genes, 54 drugs (DrugBank) and 91 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 71 diseases
Amyotrophic lateral sclerosis
38 genes, 55 drugs (DrugBank) and 109 diseases
C-type lectin receptor signaling pathway
27 genes, 66 drugs (DrugBank) and 102 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
Chagas disease
31 genes, 56 drugs (DrugBank) and 87 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Cytokine-cytokine receptor interaction
89 genes, 142 drugs (DrugBank) and 110 diseases
Cytosolic DNA-sensing pathway
20 genes, 16 drugs (DrugBank) and 31 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Graft-versus-host disease
28 genes, 25 drugs (DrugBank) and 64 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
Herpes simplex virus 1 infection
70 genes, 80 drugs (DrugBank) and 107 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human T-cell leukemia virus 1 infection
59 genes, 74 drugs (DrugBank) and 96 diseases
Huntington disease
26 genes, 39 drugs (DrugBank) and 87 diseases
IL-17 signaling pathway
20 genes, 61 drugs (DrugBank) and 86 diseases
Inflammatory bowel disease
37 genes, 46 drugs (DrugBank) and 70 diseases
Inflammatory mediator regulation of TRP channels
25 genes, 53 drugs (DrugBank) and 65 diseases
Influenza A
65 genes, 78 drugs (DrugBank) and 98 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Legionellosis
9 genes, 23 drugs (DrugBank) and 64 diseases
Leishmaniasis
40 genes, 68 drugs (DrugBank) and 102 diseases
Lipid and atherosclerosis
51 genes, 71 drugs (DrugBank) and 103 diseases
Malaria
16 genes, 32 drugs (DrugBank) and 71 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
Measles
42 genes, 63 drugs (DrugBank) and 68 diseases
Motor proteins
25 genes, 10 drugs (DrugBank) and 21 diseases
Necroptosis
32 genes, 52 drugs (DrugBank) and 77 diseases
NF-kappa B signaling pathway
22 genes, 77 drugs (DrugBank) and 91 diseases
NOD-like receptor signaling pathway
32 genes, 51 drugs (DrugBank) and 74 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
Osteoclast differentiation
38 genes, 86 drugs (DrugBank) and 102 diseases
Parkinson disease
24 genes, 76 drugs (DrugBank) and 68 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
Pertussis
22 genes, 46 drugs (DrugBank) and 73 diseases
Phagosome
37 genes, 16 drugs (DrugBank) and 30 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Prostate cancer
24 genes, 57 drugs (DrugBank) and 89 diseases
Rheumatoid arthritis
38 genes, 59 drugs (DrugBank) and 87 diseases
Salmonella infection
30 genes, 46 drugs (DrugBank) and 75 diseases
Shigellosis
29 genes, 51 drugs (DrugBank) and 92 diseases
Th17 cell differentiation
56 genes, 80 drugs (DrugBank) and 108 diseases
TNF signaling pathway
23 genes, 61 drugs (DrugBank) and 90 diseases
Toll-like receptor signaling pathway
41 genes, 65 drugs (DrugBank) and 79 diseases
Transcriptional misregulation in cancer
28 genes, 60 drugs (DrugBank) and 79 diseases
Tuberculosis
66 genes, 73 drugs (DrugBank) and 98 diseases
Type I diabetes mellitus
32 genes, 25 drugs (DrugBank) and 70 diseases
Viral protein interaction with cytokine and cytokine receptor
17 genes, 32 drugs (DrugBank) and 68 diseases
Yersinia infection
27 genes, 45 drugs (DrugBank) and 79 diseases